These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12507840)

  • 41. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A; Koncan R; Bahar G; Cornaglia G
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cloned
    Oryaşın E; Bıyık HH; Tristram S; Bozdoğan B
    Microb Drug Resist; 2020 Jul; 26(7):747-751. PubMed ID: 31971866
    [No Abstract]   [Full Text] [Related]  

  • 43. Characterisation of the main clones of Streptococcus pyogenes carrying the ermA (subclass TR) gene in Spain.
    Montes M; Orden B; Tamayo E; Alos JI; Pérez-Trallero E
    Int J Antimicrob Agents; 2006 Nov; 28(5):408-12. PubMed ID: 17000084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of Streptococcus pyogenes strains isolated from Chinese children with scarlet fever.
    Liang Y; Shen X; Huang G; Wang C; Shen Y; Yang Y
    Acta Paediatr; 2008 Dec; 97(12):1681-5. PubMed ID: 18691162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
    Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
    Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
    Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro selection of resistance to clindamycin related to alterations in the attenuator of the erm(TR) gene of Streptococcus pyogenes UCN1 inducibly resistant to erythromycin.
    Fines M; Gueudin M; Ramon A; Leclercq R
    J Antimicrob Chemother; 2001 Sep; 48(3):411-6. PubMed ID: 11533008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.
    Alós JI; Aracil B; Oteo J; Gómez-Garcés JL;
    J Antimicrob Chemother; 2003 Feb; 51(2):333-7. PubMed ID: 12562699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic susceptibility pattern and erythromycin resistance mechanisms in beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis isolates from central Taiwan.
    Lo HH; Nien HH; Cheng YY; Su FY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):613-7. PubMed ID: 24856419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020-2021.
    Powell LM; Choi SJ; Chipman CE; Grund ME; LaSala PR; Lukomski S
    Emerg Infect Dis; 2023 May; 29(5):898-908. PubMed ID: 37080963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes.
    Ardanuy C; Tubau F; Liñares J; Domínguez MA; Pallarés R; Martín R;
    Antimicrob Agents Chemother; 2005 Feb; 49(2):827-9. PubMed ID: 15673780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile.
    Palavecino EL; Riedel I; Duran C; Bajaksouzian S; Joloba M; Davies T; Appelbaum PC; Jacobs MR
    Int J Antimicrob Agents; 2002 Aug; 20(2):108-12. PubMed ID: 12297359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular Characteristics of Erythromycin-Resistant Streptococcus pyogenes Strains Isolated from Children Patients in Tunis, Tunisia.
    Ksia S; Smaoui H; Hraoui M; Bouafsoun A; Boutiba-Ben Boubaker I; Kechrid A
    Microb Drug Resist; 2017 Jul; 23(5):633-639. PubMed ID: 27991848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
    Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Relation of pbp2B, ermB, ermA/B, mefA genes with resistance to penicillin and erythromycin among Streptococcus pneumoniae isolates from children].
    Ding YF; Zhang JH; Mi ZH; Tao YZ; Qin L
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):364-7. PubMed ID: 15924755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany.
    Asmah N; Eberspächer B; Regnath T; Arvand M
    J Med Microbiol; 2009 Feb; 58(Pt 2):222-227. PubMed ID: 19141740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study of macrolide-resistant genes in group C and G streptococci].
    Seral C; González V; Castillo J; García C; Rubio MC; Gómez-Lus R
    Rev Esp Quimioter; 2000 Jun; 13(2):171-5. PubMed ID: 10918090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
    Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
    J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of an erm(T) gene in strains of inducibly clindamycin-resistant group B Streptococcus.
    Dipersio LP; Dipersio JR
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):189-93. PubMed ID: 16989973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
    Morosini MI; Cantón R; Loza E; del Campo R; Almaraz F; Baquero F
    J Antimicrob Chemother; 2003 Jul; 52(1):50-5. PubMed ID: 12805254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.